Gabriele Monte

Weitere Beteiligungen

• 08.12.2022

  16:00 – 16:05 3 Min. 2 Min.

  • ePoster
  • P49

  Use of anti-CGRP monoclonal antibodies in pediatric migraine: first evaluations of a phase 3, randomized, double-blind, placebo-controlled study

   CGRP inhibitors in the clinic, Headache in children and adolescents
• 09.12.2022

  15:40 – 15:45 3 Min. 2 Min.

  • ePoster
  • P228

  Interictal cognitive performance in children and adolescents with primary headache: a narrative review

   Headache in children and adolescents
• 09.12.2022

  15:55 – 16:00 3 Min. 2 Min.

  • ePoster
  • P232

  Long-term effects of pandemic of Covid-19 on clinical features and psychological symptoms in adolescents with migraine

   Headache in children and adolescents , Migraine
• 09.12.2022

  16:00 – 16:05 3 Min. 2 Min.

  • ePoster
  • P233

  From the new diagnostic criteria to Covid-19 pandemic passing throught the placebo effect. What have we learned in the management of pediatric migraine over the past 5 years? The opinion of Italian pediatric headache centers

   Headache in children and adolescents
• 09.12.2022

  16:25 – 16:30 3 Min. 2 Min.

  • ePoster
  • P238

  Does symptomatic treatment help children and adolescents with chronic migraine?

   Headache in children and adolescents , Migraine
• 09.12.2022

  16:30 – 16:35 3 Min. 2 Min.

  • ePoster
  • P239

  Angelman syndrome and cyclic vomiting syndrome: a new potential association – Not all the vomiting are only vomiting!

   Headache in children and adolescents , Migraine